From: Alexithymia, anxiety and depression in patients with psoriasis: a case–control study
Patients | Control group | ttest | pvalue | |
---|---|---|---|---|
TAS | 52.62 ± 13.46 | 39.63 ± 10.21 | 7.88 | 0.001* |
DIF | 17.49 ± 6.27 | 13.69 ± 5.38 | 4.70 | 0.001* |
DDF | 13.72 ± 4.93 | 10.74 ± 4.69 | 4.46 | 0.001* |
EOT | 21.34 ± 5.51 | 15.59 ± 4.60 | 8.19 | 0.001* |
HADS | 10.99 ± 7.03 | 10.05 ± 5.52 | 1.07 | 0.28 |
HADS-D | 5.16 ± 3.83 | 4.76 ± 2.93 | 0.86 | 0.39 |
HADS-A | 5.82 ± 4.01 | 5.29 ± 3.34 | 1.04 | 0.30 |